1. Market Research
  2. > Pathology Industry

Leukemia Industry, February 2016 Market Reports from Top Publishers

You might be interested in: Diagnostics, In Vitro Instrument, Flow Cytometry, Molecular Diagnostic, Pap Smear, Therapeutics, Blood Supply, Clinical Trial, Pharmaceutical, Antibody, Biomarker, Cancer Diagnostic.


 
1-10 of about 100 reports for Leukemia

Purchase Reports From Reputable Market Research Publishers

Meningeal Leukemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

Meningeal Leukemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

  • $ 2 000
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s Report, “Meningeal Leukemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase ...

Global Leukemia Partnering 2010 to 2016

Global Leukemia Partnering 2010 to 2016

  • $ 1 495
  • Industry report
  • February 2016
  • by Currentpartnering

The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world’s leading healthcare companies. • ...

Global Acute and Chronic Myelogenous Leukemia Partnering 2010 to 2016

Global Acute and Chronic Myelogenous Leukemia Partnering 2010 to 2016

  • $ 1 495
  • Industry report
  • February 2016
  • by Currentpartnering

The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world’s leading healthcare companies. • ...

Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

  • $ 2 000
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s Report, “Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights ...

 T-Cell Leukemia-Pipeline Insights, 2016

T-Cell Leukemia-Pipeline Insights, 2016

  • $ 1 250
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s, “ T-Cell Leukemia-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the T-Cell Leukemia. The Delv ...

 Hairy Cell Leukemia-Pipeline Insights, 2016

Hairy Cell Leukemia-Pipeline Insights, 2016

  • $ 1 250
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s, “ Hairy Cell Leukemia-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Hairy Cell Leukemia. The ...

 Refractory Leukemia-Pipeline Insights, 2016

Refractory Leukemia-Pipeline Insights, 2016

  • $ 1 250
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s, “ Refractory Leukemia-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Refractory Leukemia. The ...

 Mast Cell Leukemia-Pipeline Insights, 2016

Mast Cell Leukemia-Pipeline Insights, 2016

  • $ 1 250
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s, “ Mast Cell Leukemia-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Mast Cell Leukemia. The ...

B-Cell Chronic Lymphocytic Leukemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

B-Cell Chronic Lymphocytic Leukemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

  • $ 2 000
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s Report, “B-Cell Chronic Lymphocytic Leukemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, ...

 Acute Promyelocytic Leukemia-Pipeline Insights, 2016

Acute Promyelocytic Leukemia-Pipeline Insights, 2016

  • $ 1 250
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s, “ Acute Promyelocytic Leukemia-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Acute Promyelocytic ...

About 2 600 reports for Leukemia

Download Unlimited Documents from Trusted Public Sources

Economic Analysis

  • January 2014
    7 pages
  • Leukemia  

    Cancer  

View report >

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.